Eleven-Year Outcomes of a Screening Project for Abdominal Aortic Aneurysm (AAA) in 65-Year-Old Men.


Journal

Vascular health and risk management
ISSN: 1178-2048
Titre abrégé: Vasc Health Risk Manag
Pays: New Zealand
ID NLM: 101273479

Informations de publication

Date de publication:
2023
Historique:
received: 29 03 2023
accepted: 13 06 2023
medline: 25 7 2023
pubmed: 24 7 2023
entrez: 24 7 2023
Statut: epublish

Résumé

Since 2011, the Department of Vascular Surgery at Oslo University Hospital has offered screening for abdominal aortic aneurysm (AAA) to 65-year-old men living in Oslo, Norway. The aim of this study was to evaluate the effect of the screening project on AAA-related mortality and rupture and repair rates in the screened population. This cohort study included men that participated in AAA screening at the Department of Vascular Surgery at Oslo University Hospital in the period May 2011 to September 2019. All men with screen-detected AAA (aortic diameter ≥30 mm) and subaneurysmal aortic dilatation (aortic diameter 25-29 mm) were included. A stratified (1:1 with the subaneurysm group), randomized selection of men with normal aortic diameter (<25 mm) upon screening was also included. The follow-up data on events (ruptures, repairs, and deaths) after screening were collected retrospectively from patient electronic medical records at Oslo University Hospital, the National Population Register and the Norwegian Cause of Death Registry (CoDR). In total, 2048 men were included, with a median follow-up time of 7.1 years (IQR 3.8). Among men with screen-detected AAA, 0.6% died of AAA-related causes (0.9 AAA-related deaths per 1000 person-years). The rupture rate was 0.3% among men with screen-detected AAA or subaneurysmal aortic dilatation, giving an incidence of 0.5 ruptures per 1000 person-years. The overall repair rate in the AAA group was 20.6% (36.1 repairs per 1000 person-years) and 0.6% (0.9 repairs per 1000 person-years) in the subaneurysm group. In a population screened for AAA, the incidence of rupture and the AAA-related mortality was very low. Almost one-fifth of the participants with screen-detected AAA underwent elective repair, representing a group that might have presented with rupture if untreated. These results indicate that screening is valuable in preventing AAA rupture and AAA-related mortality.

Identifiants

pubmed: 37485231
doi: 10.2147/VHRM.S412954
pii: 412954
pmc: PMC10361273
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

459-467

Informations de copyright

© 2023 Mansoor et al.

Déclaration de conflit d'intérêts

The authors received no financial support and have no conflicts of interest to report.

Références

Eur J Vasc Endovasc Surg. 2021 Sep;62(3):380-386
pubmed: 34362628
Eur J Vasc Endovasc Surg. 2020 Mar;59(3):385-397
pubmed: 31899100
Br J Surg. 2013 Oct;100(11):1405-13
pubmed: 24037558
Ann Vasc Surg. 2022 Jul;83:158-167
pubmed: 34933105
Angiology. 2020 Aug;71(7):641-649
pubmed: 32351123
Br J Surg. 2011 May;98(5):619-22
pubmed: 21374589
Br J Surg. 2012 Dec;99(12):1649-56
pubmed: 23034729
Eur J Vasc Endovasc Surg. 2019 Jan;57(1):8-93
pubmed: 30528142
J Vasc Surg. 2016 Jan;63(1):55-61
pubmed: 26474507
Br J Surg. 2018 Jan;105(1):68-74
pubmed: 29265406
Br J Surg. 1995 Aug;82(8):1066-70
pubmed: 7648155
BMJ. 2005 Apr 2;330(7494):750
pubmed: 15757960
Cochrane Database Syst Rev. 2007 Apr 18;(2):CD002945
pubmed: 17443519
BMJ. 2009 Jun 24;338:b2307
pubmed: 19553269
BMJ. 2012 May 04;344:e2958
pubmed: 22563092
J Vasc Surg. 2019 Oct;70(4):1123-1129
pubmed: 30922750
JAMA. 2019 Dec 10;322(22):2219-2238
pubmed: 31821436
J Vasc Surg. 2016 Dec;64(6):1855-1868
pubmed: 27871502
Lancet. 2014 Mar 15;383(9921):963-9
pubmed: 24629298
J Cardiovasc Surg (Torino). 2017 Dec;58(6):848-853
pubmed: 28633519
Br J Surg. 2016 Feb;103(3):199-206
pubmed: 26620854
Eur J Vasc Endovasc Surg. 2013 Feb;45(2):128-34
pubmed: 23273900
Vasc Health Risk Manag. 2021 Sep 10;17:561-570
pubmed: 34531660
Ann Vasc Surg. 2021 Apr;72:488-497
pubmed: 32949734
Lancet. 2002 Nov 16;360(9345):1531-9
pubmed: 12443589
Circulation. 2016 Oct 18;134(16):1141-1148
pubmed: 27630132
Circulation. 2019 Mar 12;139(11):1371-1380
pubmed: 30636430
BMJ. 2004 Nov 27;329(7477):1259
pubmed: 15545293
Eur J Vasc Endovasc Surg. 2020 Jan;59(1):16-22
pubmed: 31810836
Br J Surg. 2016 Nov;103(12):1634-1639
pubmed: 27508946
Angiology. 2018 Mar;69(3):205-211
pubmed: 28193091

Auteurs

Saira Mauland Mansoor (SM)

Department of Vascular Surgery, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

Toril Rabben (T)

Department of Vascular Surgery, Oslo University Hospital, Oslo, Norway.

Jonny Hisdal (J)

Department of Vascular Surgery, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

Jørgen Joakim Jørgensen (JJ)

Department of Vascular Surgery, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Department of Traumatology, Oslo University Hospital, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH